PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Independence Blue CrossCommercial · Administrative · Pharmacy · Ophthalmology, PharmacyLow impact

08.01.44c, Voretigene Neparvovec-rzyl (Luxturna®)

Effective date
Not stated in the notice
Identified
Jun 19, 2026

Summary

This is a reissue with no material changes to Independence Blue Cross's policy on Luxturna (voretigene neparvovec-rzyl) for RPE65-associated retinal dystrophy. The policy maintains existing coverage criteria, HCPCS code J3398, and medical necessity requirements. No billing workflow updates are required.

Get alerts when payers change rules like this one

We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

Action · 3 steps
01No action required.
02This is a routine annual policy reissue with no substantive changes to coverage, billing codes, or documentation requirements.
03Billing team should maintain existing procedures for Luxturna claims under HCPCS code J3398, ensuring all medical necessity criteria are met before submission.

Codes mentioned

J3398

Original notice

08.01.44c, Voretigene Neparvovec-rzyl (Luxturna®)
medpolicy.ibx.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account